Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERIPATEI: Rehabilitation Walking Program with Transient NSAID for Hip/Knee Osteoarthritis
NCT05761015Phase 4Recruiting
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Dec 2023
- Primary completion
- Apr 2028
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial in osteoarthritis (OA), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Success at 12 weeks. Started Dec 2023; status: recruiting.
02
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05761015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05761015.